An interventional study of Use of C-Polar coated HVAC Filter versus conventional HVAC Filter in Air Pollution, sponsored by C-Polar Innovations. Not yet recruiting at 1 site in Canada. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-22.
Sponsored by C-Polar Innovations · Not applicable, Interventional, and Health services research
This is a CONTROLLED PROSPECTIVE COHORT study of a long-term care facility. At the start of the study a dedicated section A of the facility ventilation system will have routine HVAC filters of the same dimensions installed, while section B of the same facility ventilation system will have C-POLAR (cationic polymeric coated) HVAC filters installed. There will be continuous Indoor Air Quality monitors (PM 2.5, CO2, VOC, Radon, Temp, and RH) installed at different vent locations throughout the long-term care facility for the duration of the study. Air samples with an Airport MD8 BAMS machine will be taken once a week at various vent locations at the long-term care facility.
This is a CONTROLLED PROSPECTIVE COHORT study of a long-term care facility. At the start of the study a dedicated section A of the facility ventilation system will have routine HVAC filters of the same dimensions installed, while section B of the same facility ventilation system will have C-POLAR (cationic polymeric coated) HVAC filters installed. There will be continuous Indoor Air Quality monitors (PM 2.5, CO2, VOC, Radon, Temp, and RH) installed at different vent locations throughout Cottonwoods for the duration of the study. Air samples with an Airport MD8 BAMS machine will be taken once a week at various vent locations at the long-term care facility. The aim of this study is to determine the difference in reduction of bioaerosols in a long-term care facility with MERV 13 C-POLAR (cationic polymeric coated) HVAC filters compared to conventional MERV 13 HVAC filters.
Primary Endpoint:
This study aims to determine the reduction of bioaerosols (BAMS) in a facility with a C-POLAR HVAC filter building intervention versus conventional filters.
Secondary Endpoints:
Radon gas testing, particulate matter testing (PM2.5) [fine inhalable particles, with diameters that are generally 2.5 micrometers and smaller]. Carbon dioxide testing (CO2), VOCs testing [volatile organic compounds (airborne chemicals)], relative humidity (RH) testing [it is a measure of the actual amount of water vapor in the air compared to the total amount of vapor that can exist in the air at its current temperature], and temperature readings.
This is the only study on the registry with C-Polar Innovations as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
comparing the difference in reduction of bioaerosols between HVAC filters.
Other: Use of C-Polar coated HVAC Filter versus conventional HVAC Filter
comparing the difference in reduction of bioaerosols between HVAC filters.
Also known as: comparing the difference in reduction of bioaerosols between HVAC filters.
The primary endpoint is comparing the difference in reduction of bioaerosols between MERV 13 HVAC filters.
The aim of this study is to determine the difference in reduction of bioaerosols in a long-term care facility with MERV 13 C-POLAR (cationic polymeric coated) HVAC filters compared to conventional MERV 13 HVAC filters.
Time frame: Nine Months
Plan to share: No — All participant data will be anonymized
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.